1. Menopause and Bone Loss
Menopause is the single most significant turning point for bone health in women. Estrogen, a hormone that declines sharply after menopause, plays a crucial role in maintaining bone density by inhibiting the activity of osteoclasts—cells that break down bone. When estrogen levels drop, this protective effect diminishes, accelerating bone loss.
In practical terms, women can lose up to 20 percent of their bone density in the five to seven years following menopause. This rapid bone loss happens silently, without pain or symptoms, making it difficult to detect without testing. This is why the U.S. Preventive Services Task Force recommends bone density screening for all women aged 65 and older and for younger postmenopausal women who have risk factors.
Understanding this mechanism underscores the importance of early screening and intervention. Lifestyle changes, calcium and vitamin D intake, and, in some cases, medications can help slow down or prevent significant bone loss after menopause.
2. Previous Fragility Fractures
A history of fragility fractures is one of the strongest predictors of future fractures and an indication for immediate bone density testing. Fragility fractures are breaks that occur from a fall at standing height or less, commonly involving the wrist, hip, or spine, and they often go unnoticed as signs of underlying osteoporosis.
People over 50 who have experienced such fractures should be highly vigilant. These fractures suggest that bones are already weakened, and without intervention, the risk of subsequent fractures increases significantly. Healthcare providers use this information to prioritize bone health evaluations and consider treatments that reduce fracture risk.
If you have had a fracture from a minor fall, it is essential to inform your doctor and discuss a DEXA scan. Medicare covers this painless, low-radiation bone density test every 24 months for qualified individuals, making it accessible and an essential tool in preventing debilitating fractures.
